These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 125386)

  • 21. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 22. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 23. [A review on neurotransmitter in clinical neurology (author's transl)].
    Kanazawa I
    No To Shinkei; 1977 Dec; 29(12):1245-60. PubMed ID: 74257
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical neurology.
    Boshes B; Brumlik J; Blonsky ER
    Prog Neurol Psychiatry; 1968; 23():155-97. PubMed ID: 4890078
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biochemical aspects of involuntary movements (author's transl)].
    Nakamura S; Kameyama M
    No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
    Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurochemical basis for pathological motor activity].
    Hole K
    Tidsskr Nor Laegeforen; 1974 Jan; 94(1):11-7. PubMed ID: 4362478
    [No Abstract]   [Full Text] [Related]  

  • 30. The dopamine transporter: role in neurotoxicity and human disease.
    Bannon MJ
    Toxicol Appl Pharmacol; 2005 May; 204(3):355-60. PubMed ID: 15845424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Symposium on diseases of the basal ganglia. Physiological and clinical implications of thalamic surgery for dystonia and torticollis. II].
    Cooper IS
    Rev Bras Med; 1968 Nov; 25(11):774-80. PubMed ID: 4388626
    [No Abstract]   [Full Text] [Related]  

  • 32. [Abnormal neurotransmission in neurological diseases (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
    [No Abstract]   [Full Text] [Related]  

  • 33. Catecholamine metabolism in health and disease.
    Hoeldtke R
    Metabolism; 1974 Jul; 23(7):663-83. PubMed ID: 4365898
    [No Abstract]   [Full Text] [Related]  

  • 34. Respiratory problems in neurologic movement disorders.
    Mehanna R; Jankovic J
    Parkinsonism Relat Disord; 2010 Dec; 16(10):628-38. PubMed ID: 20674459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
    Wray SR; Melville GN; Grell GA; Edge PC
    West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical effects of chronic L-dopa treatment in rats: implications for emergence of tolerance phenomena in patients with Parkinson's disease.
    Melamed E; Globus M; Rosenthal J; Uzzan A
    Adv Neurol; 1987; 45():507-10. PubMed ID: 3825730
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemistry of the basal ganglia.
    Fahn S
    Adv Neurol; 1976; 14():59-89. PubMed ID: 7932
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of manganese in dystonia.
    Barbeau A; Inoué N; Cloutier T
    Adv Neurol; 1976; 14():339-52. PubMed ID: 821321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
    Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
    J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
    Price KS; Farley IJ; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.